155 related articles for article (PubMed ID: 15859541)
1. [Treatment of chronic hepatitis with interferon in children with kidney diseases].
Szczepańska M; Tobis A; Schneiberg B; Szprynger K; Kobos E; Morawiec-Knysak A
Pol Merkur Lekarski; 2005 Jan; 18(103):22-8. PubMed ID: 15859541
[TBL] [Abstract][Full Text] [Related]
2. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
[TBL] [Abstract][Full Text] [Related]
3. Interferon treatment in children with chronic hepatitis B: an Israeli experience.
Hartman C; Hager H; Berkowitz D; Rimon N; Bassan L; Trogouboff P; Teitler A; Shamir R
Isr Med Assoc J; 2002 Nov; 4(11 Suppl):914-8. PubMed ID: 12455179
[TBL] [Abstract][Full Text] [Related]
4. Chronic hepatitis B virus in children in Israel: clinical and epidemiological characteristics and response to interferon therapy.
Neudorf-Grauss R; Bujanover Y; Dinari G; Broide E; Neveh Y; Zahavi I; Reif S
Isr Med Assoc J; 2000 Feb; 2(2):164-8. PubMed ID: 10804945
[TBL] [Abstract][Full Text] [Related]
5. [Interferon treatment of chronic viral hepatitis in Catalonia, Spain. Retrospective analysis].
Buti M; Bruguera M; Casany S; Gaspar MJ; Esteban R
Gastroenterol Hepatol; 1999 Mar; 22(3):127-31. PubMed ID: 10228322
[TBL] [Abstract][Full Text] [Related]
6. [The neuropsychiatric side effects of the interferon therapy in patients with chronic hepatitis B and C].
Lapiński TW; Prokopowicz D
Pol Merkur Lekarski; 1999 Jul; 7(37):8-11. PubMed ID: 10522402
[TBL] [Abstract][Full Text] [Related]
7. Long-term lamivudine therapy for chronic hepatitis B infection in children unresponsive to interferon.
Hartman C; Berkowitz D; Eshach-Adiv O; Hino B; Rimon N; Satinger I; Kra-Oz T; Shamir R
J Pediatr Gastroenterol Nutr; 2006 Oct; 43(4):494-8. PubMed ID: 17033525
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies in children with chronic hepatitis B infection and the influence of interferon alpha.
Kansu A; Kuloğlu Z; Demirçeken F; Girgin N
Turk J Gastroenterol; 2004 Dec; 15(4):213-8. PubMed ID: 16249973
[TBL] [Abstract][Full Text] [Related]
9. Effect of IFN-alpha on total haemolytic activity of CH50 complement system and C3, C4 levels in children with chronic hepatitis C.
Woźniakowska-Gesicka T; Wiśniewska-Ligier M; Kupś J
Med Sci Monit; 2001 May; 7 Suppl 1():202-6. PubMed ID: 12211720
[TBL] [Abstract][Full Text] [Related]
10. Long-term lamivudine treatment of children with chronic hepatitis B: durability of therapeutic responses and safety.
Jonas MM; Little NR; Gardner SD;
J Viral Hepat; 2008 Jan; 15(1):20-7. PubMed ID: 18088241
[TBL] [Abstract][Full Text] [Related]
11. Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients.
Sarin SK; Kumar M; Kumar R; Kazim SN; Guptan RC; Sakhuja P; Sharma BC
Am J Gastroenterol; 2005 Nov; 100(11):2463-71. PubMed ID: 16279901
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerance of interferon-alpha in the treatment of chronic hepatitis C in end-stage renal disease patients on hemodialysis.
Rocha CM; Perez RM; Ferreira AP; Carvalho-Filho RJ; Pace FH; Silva IS; Pestana JO; Lanzoni VP; Silva AE; Ferraz ML
Liver Int; 2006 Apr; 26(3):305-10. PubMed ID: 16584392
[TBL] [Abstract][Full Text] [Related]
13. Treatment of chronic hepatitis B virus infection - Dutch national guidelines.
Buster EH; van Erpecum KJ; Schalm SW; Zaaijer HL; Brouwer JT; Gelderblom HC; de Knegt RJ; Minke Bakker C; Reesink HW; Janssen HL;
Neth J Med; 2008; 66(7):292-306. PubMed ID: 18663260
[TBL] [Abstract][Full Text] [Related]
14. Long-term therapeutic efficacy of lamivudine compared with interferon-alpha in children with chronic hepatitis B: the younger the better.
Choe BH; Lee JH; Jang YC; Jang CH; Oh KW; Kwon S; Hyun MC; Ko CW; Lee KS; Lee WK
J Pediatr Gastroenterol Nutr; 2007 Jan; 44(1):92-8. PubMed ID: 17204960
[TBL] [Abstract][Full Text] [Related]
15. [Treatment with natural interferon (alfaferone) in clinical practice--our experience].
Dybowska D; Halota W
Przegl Epidemiol; 2007; 61(1):17-22. PubMed ID: 17702434
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis-B virus associated nephropathies: a clinicopathological study in 14 children.
Ozdamar SO; Gucer S; Tinaztepe K
Pediatr Nephrol; 2003 Jan; 18(1):23-8. PubMed ID: 12488986
[TBL] [Abstract][Full Text] [Related]
17. [The assessment of nutritional status in children with chronic hepatitis B treated with interferon alpha].
Lebensztejn DM; Zagórecka E; Kaczmarski M; Piotrowska-Jastrzebska J
Pol Merkur Lekarski; 2001 Jul; 11(61):29-31. PubMed ID: 11579826
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B in children: complexities in management.
Kerkar N
Pediatr Transplant; 2005 Oct; 9(5):685-91. PubMed ID: 16176431
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of lamivudine-induced HBsAg loss rate according to age in children with chronic hepatitis B].
Kim JM; Choe BH; Chu MA; Cho SM
Korean J Hepatol; 2009 Jun; 15(2):168-78. PubMed ID: 19581769
[TBL] [Abstract][Full Text] [Related]
20. Effect of interferon on incidence of hepatocellular carcinoma in patients with chronic hepatitis C.
Soga K; Shibasaki K; Aoyagi Y
Hepatogastroenterology; 2005; 52(64):1154-8. PubMed ID: 16001651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]